AI주식인사이트AI Stock Insight
B

에이프로젠바이오로직스

003060KOSPI

55.7 / 100

Reference Date: 2026-09-08

Financial Score19.5 / 40
News Sentiment15.2 / 25
Momentum9.0 / 20
Disclosure12.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 15.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Aprogen BioLogics operates two business segments: a pharmaceutical division producing synthetic drugs and a biopharmaceutical division manufacturing biologics. Its Cheongju-based Osong facility boasts world-class antibody production capacity, capable of producing over 2.8 million liters of culture media annually. The affiliated company Aprogen Pharma focuses on drug distribution, though the group reported an operating loss as of 2023.

Number of Employees

445people

Average Salary

47.4M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
0.10Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
-51.29Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
28.93Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20250.5 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼7.1% (2-year basis)

Operating Profit Growth Rate
0.5 / 3

Avg ▼3.1% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -35.2% (declining, 3yr)

Detailed News Sentiment

7 totalPositive 2Neutral 5Negative 0Average Sentiment Score 60.7

Detailed Momentum

52-week position3.0Point

52w lower range (32%)

Current 1,818Won52-week high 5,10052-week low 235
1-month return0.0Point

1m -15.83% (strong drop)

Volume trend6.0Point

Volume surge

Detailed Disclosure

7 totalPositive 1Neutral 6Negative 0
  • Positive주요사항보고서(유상증자결정)2026-09-03
  • Neutral주식등의대량보유상황보고서(약식)2026-09-02
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-09-02
  • Neutral주식등의대량보유상황보고서(일반)2026-09-02
  • Neutral주식등의대량보유상황보고서(일반)2026-08-21